Lamaline is a level II analgesic combination of paracetamol, diopium powder and caffeine, prescribed to relieve moderate to intense pain when conventional analgesics are not enough. This prescription medicine requires rigorous use because of its opiate composition. We discuss in this guide:
- Therapeutic indications and presentations available
- Precise dosage and absolute contraindications
- Precautions for use and drug interactions
- Side effects and risk of addiction
- Practical tips for secure use
What is Lamaline?
Lamaline belongs to the class of level II analgesics according to the World Health Organization classification. Its unique formulation combines three complementary active ingredients: paracetamol as antalgic and antipyretic, the powder of diopium for its powerful morphinic action, and caffeine that potentiates the analgic effect while contrasting the somnolence induced by the opium.
This synergistic combination results in an analgesic efficacy greater than that of each individual component. The drug is listed in List I of poisonous substances, which explains its dispensation strictly on prescription.
When to use Lamaline
We prescribe Lamaline in situations where moderate to severe pain requires enhanced therapeutic management. The medicinal product finds its place when level I analgesics (paracetamol, aspirin, ibuprofen alone) are insufficient to provide satisfactory relief.
The indications include post-operative pain, severe dental pain, some rheumatism pain, headaches that are resistant to the usual treatments, or pain associated with chronic conditions requiring temporary antalgia.
The various presentations available
Lamaline comes in two galenic forms adapted to different contexts of use. The hard capsules, intended for oral use, contain 300 mg paracetamol, approximately 10 mg powder of diopium and 30 mg caffeine. This presentation is suitable for most situations and allows easy administration.
The rectal suppositories contain 500 mg of paracetamol, the same amount of powder, and 50 mg of caffeine. This form is particularly useful in patients who have difficulty swallowing, vomiting, or who require different absorption of the active substance.
Composition and active ingredients of Lamaline
Each component of Lamaline plays a specific therapeutic role in the management of pain. Paracetamol acts centrally by inhibiting the synthesis of prostaglandins in the central nervous system, providing analgesic and antipyretic action without significant anti-inflammatory effect.
The key element of this association is the powder of the diopium, morphine base. It acts on central and peripheral opioid receptors, generating strong antalgia but exposing to adverse effects and the risk of dependence characteristic of morphines.
Caffeine completes this formulation by stimulating the central nervous system, partially counterbalancing opiate sedation and potentiating the analgesic effect by a mechanism of pharmacological synergy.
Posology and method of administration
The use of Lamaline is strictly limited to adults and adolescents over the age of 15. For capsules, we recommend 1 to 2 units, 3 to 5 times a day, without exceeding 10 capsules daily. The minimum interval between doses should be 4 hours, increased to 8 hours in patients with severe renal impairment.
For the suppositories, the dose is set at 1 unit, 2 to 3 times a day, with a maximum of 6 daily suppositories. This dose difference takes into account the higher paracetamol dosage of this form.
The administration of capsules requires a large glass of water to facilitate swallowing and optimize dissolution. The daily limit of paracetamol should never exceed 4 g per day, reduced to 3 g in patients weighing less than 50 kg, elderly, or those with hepatic, renal, alcohol or malnutrition impairment.
Contraindications to be known
Several situations formally prohibit the use of Lamaline. The known allergy to one of the components is an absolute contraindication, as is the age below 15 years due to the risks associated with opiate derivatives in children.
Severe hepatic impairment completely excludes this treatment, as paracetamol is metabolised by the liver and may aggravate pre-existing liver damage. Severe respiratory pathologies, including decompensated asthma and respiratory failure, also counter-indicated Lamaline due to the respiratory depressive effect of the opium.
Breastfeeding is a major contraindication, as morphine may pass into breast milk and affect the infant. Finally, the combination with certain morphine medicinal products (nalbuphine, buprenorphine, pentazocin) or their antagonists (naltrexone, nalmefen) is formally prohibited.
Precautions for use and warnings
The use of Lamaline requires special vigilance in several clinical situations. We stress the need to avoid cumulation with other specialties containing paracetamol, a major risk of hepatotoxic overdose often unknown to patients.
The potential for physical and psychological dependence, inherent in the presence of d Stopping must be done gradually to avoid withdrawal syndrome.
Increased caution is required in elderly people, patients under 50 kg, patients with renal or hepatic impairment, chronic alcoholism, malnutrition, intracranial hypertension, urinary or prostatic pathologies, or patients with a history of epileptic disease.
Interaction with other medicinal products and substances
The drug interactions of Lamaline require special attention because of its complex composition. The combination with morphine antagonists (pentazocin, buprenorphine, nalbuphine) or pure antagonists (naltrexone, nalmefen) is absolutely contraindicated, risking precipitating acute withdrawal syndrome.
Co-administration of sedative drugs (benzodiazepines, hypnotics, neuroleptics, sedative antidepressants) dangerously increases central nervous system depression. Oral anticoagulants are potentiated by the prolonged use of paracetamol, requiring increased surveillance of INR.
Some antibiotics such as flucloxacilline may cause metabolic acidosis in combination with paracetamol. Caffeine-containing medicines may combine stimulating effects, generating excitement, palpitations and insomnia.
Lamaline and consumption of alcohol or caffeine
Alcohol is a particularly dangerous association with Lamaline. The depressive effect of alcohol on the central nervous system adds to that of the opium, greatly increasing the risk of excessive sleepiness, respiratory depression and accidents. We recommend strict alcohol withdrawal throughout treatment.
Regarding caffeine, its natural presence in Lamaline should encourage limiting external intakes (coffee, tea, energy drinks, certain medicines). This precaution avoids the manifestations of excess caffeine: nervousness, tremor, palpitations, insomnia. We recommend to avoid taking Lamaline vesperal to preserve the quality of sleep.
Use during pregnancy and lactation
Pregnancy is a delicate situation that requires a rigorous assessment of the benefit-risk ratio. Lamaline is only possible if there is absolute therapeutic need, when there is no safer alternative. Chronic or end-of-pregnancy use exposes the newborn to a risk of neonatal withdrawal syndrome or respiratory depression at birth.
Breastfeeding contraindicates formally Lamaline. The morphine in the opium easily crosses the breast barrier and can accumulate in the infant, causing excessive sleepiness, difficulty feeding or even respiratory depression. The withdrawal or temporary cessation of breastfeeding is necessary during treatment.
Possible side effects
Side effects of Lamaline result from the action of its three components. The most common manifestations are somnolence, confusion, euphoria, nightmares, hallucinations, often severe constipation, nausea, vomiting, abdominal pain, dizziness, urinary retention, pruritus and rashes.
Paracetamol may cause allergic reactions (urticaria, oedema of Quincke) and, exceptionally, severe skin reactions (Lyell or Stevens-Johnson syndromes), haematological abnormalities or liver damage.
Caffeine contributes to sleep disorders, excitement, palpitations and tremors. These effects may be particularly annoying in sensitive patients or in late dosing during the day.
Risks of addiction and withdrawal syndrome
The presence of d This dependence can settle insidiously, even during appropriate therapeutic use.
Weaning syndrome is manifested by painful resurgence, agitation, anxiety, sleep disorders, sweating, nausea, sometimes muscle cramps and marked irritability. These symptoms justify a gradual discontinuation of treatment, with a gradual reduction of doses over several days to several weeks depending on the duration of exposure.
We recommend close medical monitoring during discontinuation, particularly in patients treated in the long term. Anticipation of this problem makes it possible to optimize management and limit the discomfort associated with withdrawal.
What to do in case of overdose?
The overdose of Lamaline is an absolute medical emergency requiring immediate hospitalization. Paracetamol intoxication initially occurs through nausea, vomiting, anorexia and abdominal pain, followed 24 to 48 hours later by hepatic cytolysis that may develop into fulminant hepatocellular insufficiency, renal failure, coma and death.
Opiate intoxication begins with euphoria and somnolence, progresses towards severe constipation, then may progress to major respiratory depression, convulsions, coma and death by cardiopulmonary arrest.
Hospital management combines specific antidotes (N-acetylcysteine for paracetamol, naloxone for opiate derivatives), resuscitation measures and intensive monitoring. The prognosis depends on the precocity of management and the amount ingested.
Lamaline and driving
The use of Lamaline is incompatible with driving or using dangerous machines. Opium-induced somnolence, even partially compensated by caffeine, significantly alters reflexes, alertness, and judgment capacity.
This contraindication applies from the first dose and persists until treatment is stabilized. We recommend that tolerance be assessed individually before allowing the resumption of activities requiring sustained attention.
Patients should be informed that positivity to drug testing (morphine) is possible and may have professional or judicial consequences, especially for security or transport occupations.
Therapeutic alternatives to Lamaline
Several therapeutic options can replace Lamaline depending on the clinical context. Simple level II analgesics (codein, tramadol) offer comparable efficacy with a different adverse reaction profile. Paracetamol-codein or paracetamol-tramadol combinations are frequently used alternatives.
For inflammatory pain, nonsteroidal anti-inflammatory drugs (NSAIDs) associated with paracetamol may be sufficient. Non-drug techniques (physiotherapy, relaxation, neurostimulation) should be considered as a complement or alternative.
In some situations of chronic pain, referral to specialized pain counselling helps to optimize multimodal management and limit the use of opiates.
Price, refund and availability
Lamaline receives a 65% refund from the French Sickness Insurance, a classification reflecting her status as a medicine of recognized therapeutic interest. The target price is around 1.41 € for a pack of 16 capsules and 2,27 € for a box of 10 suppositories, making this treatment economically accessible.
The dispensation is made exclusively by medical prescription in official pharmacy. The pharmacist must ensure compliance with the prescription and may issue appropriate advice for use. Split delivery is not mandatory but may be recommended to limit the risk of misuse.
| Introduction | Indicative price | Refund | Quantity |
| Capsules | 1,41 € | 65% | 16 units |
| Suppositories | 2,27 € | 65% | 10 units |
Marketing and countries where Lamaline is available
Lamaline is restricted to certain countries. In France, its placing on the market dates back to the 2000s, and the medicine is granted a permanent marketing authorisation. Tunisia is the other territory where Lamaline is regularly available, showing historical regulatory and pharmaceutical links.
This limited geographical distribution is explained by national regulatory specificities for drug combinations containing opiate derivatives. Each country applies its own risk-benefit and regulatory classification criteria.
Patients travelling abroad must anticipate supply difficulties and provide therapeutic alternatives validated by their prescribing doctor.
Practical advice
In order to optimize the effectiveness and safety of Lamaline, we recommend that you scrupulously adhere to the dose schedule and never change doses without medical advice. Keeping a follow-up notebook helps document the evolution of pain and the appearance of possible side effects.
Abundant hydration and a high fibre diet limit opiate constipation. Relaxation techniques and the practice of adapted physical activity enhance the analgesic effect and promote general well-being.
We stress the importance of keeping Lamaline out of the reach of children, in its original packaging, away from light and moisture. The expiry date must be respected, and any unused drug must be reported to the pharmacy for safe destruction.
Finally, communication with the health care team remains fundamental: any changes in the clinical condition, the appearance of adverse reactions or the questioning of treatment warrants rapid medical contact for therapeutic adaptation.
